Eisai Co. Ltd (OP: ESALF )
44.65
+6.23
(+16.23%)
Streaming Delayed Price
Updated: 3:02 PM EDT, Aug 23, 2024
Add to My Watchlist
Headline News about Eisai Co. Ltd![]()
Catalyst Pharma Acquires US Rights To Eisai's Epilepsy Drug
December 20, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]()
Merck's Two Keytruda Combo Cancer Trials Miss Primary Goal
August 03, 2022
Via Benzinga
![]()
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
Via Benzinga
![]() ![]()
Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer
September 12, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
White House Dismisses Janet Woodcock As Permanent FDA Commissioner Candidate: Bloomberg
August 20, 2021
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|